1. A proteogenomic surfaceome study identifies DLK1 as an immunotherapeutic target in neuroblastoma
- Author
-
Weiner, Amber K., primary, Radaoui, Alexander B., additional, Tsang, Matthew, additional, Martinez, Daniel, additional, Sidoli, Simone, additional, Conkrite, Karina L., additional, Delaidelli, Alberto, additional, Modi, Apexa, additional, Rokita, Jo Lynne, additional, Patel, Khushbu, additional, Lane, Maria V., additional, Zhang, Bo, additional, Zhong, Chuwei, additional, Ennis, Brian, additional, Miller, Daniel P., additional, Brown, Miguel A., additional, Rathi, Komal S., additional, Raman, Pichai, additional, Pogoriler, Jennifer, additional, Bhatti, Tricia, additional, Pawel, Bruce, additional, Glisovic-Aplenc, Tina, additional, Teicher, Beverly, additional, Erickson, Stephen W., additional, Earley, Eric Jay, additional, Bosse, Kristopher R., additional, Sorensen, Poul H., additional, Krytska, Kateryna, additional, Mosse, Yael P., additional, Havenith, Karin E., additional, Zammarchi, Francesca, additional, van Berkel, Patrick H., additional, Smith, Malcolm A., additional, Garcia, Benjamin A., additional, Maris, John M., additional, and Diskin, Sharon J., additional
- Published
- 2023
- Full Text
- View/download PDF